Assuming the protective role of ApoE3 compared to the detrimental role of ApoE4 in AD (for an extensive review see Huang et al. [26]), we can speculate the following: the binding of the peptide with ApoE3 does not affect the stability of the protein nor the complex, leading to the peptide clearance. Here, APOE is linked to Alzheimer disease.